Theranica’s Post

Despite FDA clearance for both acute and preventive treatment in ages 8 and up, along with the abundance of clinical evidence in peer-reviewed journals, only a limited number of insurance providers currently cover the Nerivio® REN wearable, leaving many people living with migraine disease without affordable access to this essential non-drug therapy. Help the many living with migraine close this gap. Join the effort to advocate for broader insurance coverage of the REN wearable, so more children, adolescents, and adults can access effective migraine treatment without relying on medication. Whether you’re a pediatrician, headache specialist, or neurologist, follow Theranica’s LinkedIn page to learn more about how you can advocate for your patients and help expand access to care.

To view or add a comment, sign in

Explore topics